LYTIR

Insider · SEC Form 4 · Director

RECANATI LEON

In the 12 months to Nov 8, 2026, on the open market: bought $692K of EVGN. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

  1. EVGNBought: Evogene Ltd. Aug 11, 2026 460,000 shares filed Aug 13, 2026 1,343,886 shares held directly after, as filed filing $292K
  2. EVGNBought: Evogene Ltd. Aug 4, 2026 800,000 shares filed Aug 5, 2026 883,886 shares held directly after, as filed filing $400K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.